InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Giacobello Scott M., Chief Financial Officer. Officer active across 2 companies, notably GW Pharmaceuticals PLC. In total, 4 disclosures have been published. History available since 26 September 2022. The latest transaction was disclosed on 26 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
6,750 sharesCommon StockSEC:0001415889-25-006318:0
20,000 shares@ US$12.50100.0% of flowCommon StockSEC:0001209191-22-051388:0
165,108 sharesOrdinary SharesSEC:0000899243-21-018661
165,108 sharesOrdinary SharesSEC:0000899243-21-018661:0
4 of 4 declarations
About Giacobello Scott M.
Scott M. Giacobello is the Chief Financial Officer at GW Pharmaceuticals PLC. In this role, he is responsible for financial management and strategy of the company, which specializes in drug development. Scott plays a key role in financial planning and compliance, thereby contributing to the growth of the firm.
